Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2023

Open Access 01-12-2023 | Kidney Cancer | Research

Expression profiles and functional prediction of histone acetyltransferases of the MYST family in kidney renal clear cell carcinoma

Authors: Fan Liang, Xiangke Li, Xiaoman Shen, Runlei Yang, Chuan Chen

Published in: BMC Cancer | Issue 1/2023

Login to get access

Abstract

Background

Histone acetyltransferases (HATs) of the MYST family are associated with a variety of human cancers. However, the relationship between MYST HATs and their clinical significance in kidney renal clear cell carcinoma (KIRC) has not yet been evaluated.

Methods

The bioinformatics method was used to investigate the expression patterns and prognostic value of MYST HATs. Western blot was used to detect the expression of MYST HATs in KIRC.

Results

The expression levels of MYST HATs except KAT8 (KAT5, KAT6A, KAT6B, and KAT7) were significantly reduced in KIRC tissues compared to normal renal tissues, and the western blot results of the KIRC samples also confirmed the result. Reduced expression levels of MYST HATs except KAT8 were significantly associated with high tumor grade and advanced TNM stage in KIRC, and showed a significant association with an unfavorable prognosis in patients with KIRC. We also found that the expression levels of MYST HATs were closely related to each other. Subsequently, gene set enrichment analysis showed that the function of KAT5 was different from that of KAT6A, KAT6B and KAT7. The expression levels of KAT6A, KAT6B and KAT7 had significant positive correlations with cancer immune infiltrates such as B cells, CD4+ T cells and CD8+ T cells.

Conclusions

Our results indicated that MYST HATs, except KAT8, play a beneficial role in KIRC.
Appendix
Available only for authorised users
Literature
1.
Cairns P. Renal cell carcinoma. Cancer biomarkers: section a of Disease markers. 2010;9(1–6):461–73.
2.
Hsieh JJ, Purdue MP, Signoretti S, Swanton C, Albiges L, Schmidinger M, et al. Renal cell carcinoma. Nat reviews Disease primers. 2017;3:17009.CrossRefPubMed
3.
Wei Q, He H, Lv L, Xu X, Sun W. The promising role of radiotherapy in the treatment of advanced or metastatic renal cell carcinoma: a narrative review. Translational Androl Urol. 2020;9(6):2821–30.CrossRef
4.
Rizzo A, Mollica V, Santoni M, Ricci AD, Rosellini M, Marchetti A, et al. Impact of Clinicopathological features on survival in patients treated with first-line Immune checkpoint inhibitors plus tyrosine kinase inhibitors for renal cell carcinoma: a Meta-analysis of Randomized clinical trials. Eur Urol focus. 2022;8(2):514–21.CrossRefPubMed
5.
Massari F, Rizzo A, Mollica V, Rosellini M, Marchetti A, Ardizzoni A, et al. Immune-based combinations for the treatment of metastatic renal cell carcinoma: a meta-analysis of randomised clinical trials. Eur J Cancer. 2021;154:120–7.CrossRefPubMed
6.
Avvakumov N, Côté J. The MYST family of histone acetyltransferases and their intimate links to cancer. Oncogene. 2007;26(37):5395–407.CrossRefPubMed
7.
Alaskhar Alhamwe B, Khalaila R, Wolf J, von Bülow V, Harb H, Alhamdan F et al. Histone modifications and their role in epigenetics of atopy and allergic diseases. Allergy, asthma, and clinical immunology: official journal of the canadian society of Allergy and Clinical Immunology. 2018;14:39.
8.
Sapountzi V, Cote J. MYST-family histone acetyltransferases: beyond chromatin. Cell Mol Life Sci. 2011;68(7):1147–56.CrossRefPubMed
9.
Demetriadou C, Kirmizis A. Histone acetyltransferases in Cancer: Guardians or Hazards? Crit Rev Oncog. 2017;22(3–4):195–218.CrossRefPubMed
10.
Neganova ME, Klochkov SG, Aleksandrova YR, Aliev G. Histone modifications in epigenetic regulation of cancer: perspectives and achieved progress. Sem Cancer Biol. 2022;83:452–71.CrossRef
11.
Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–w102.CrossRefPubMedPubMedCentral
12.
Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi B, et al. UALCAN: a portal for facilitating Tumor Subgroup Gene expression and survival analyses. Volume 19. New York, NY: Neoplasia; 2017. pp. 649–58. 8.
13.
Vasaikar SV, Straub P, Wang J, Zhang B. LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 2018;46(D1):D956–d63.CrossRefPubMed
14.
Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, et al. TIMER: a web server for Comprehensive Analysis of Tumor-Infiltrating Immune cells. Cancer Res. 2017;77(21):e108–10.CrossRefPubMedPubMedCentral
15.
Chen M, Tominaga K, Pereira-Smith OM. Emerging role of the MORF/MRG gene family in various biological processes, including aging. Ann N Y Acad Sci. 2010;1197:134–41.CrossRefPubMedPubMedCentral
16.
17.
18.
Gorrini C, Squatrito M, Luise C, Syed N, Perna D, Wark L, et al. Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response. Nature. 2007;448(7157):1063–7.CrossRefPubMed
19.
20.
Wang S, Xiang T, Yu L, Wen J, Liu F, Yang D, et al. Novel molecular subtypes and related score based on histone acetylation modification in Renal Clear Cell Carcinoma. Front cell Dev biology. 2021;9:668810.CrossRef
21.
Champagne N, Bertos NR, Pelletier N, Wang AH, Vezmar M, Yang Y, et al. Identification of a human histone acetyltransferase related to monocytic leukemia zinc finger protein. J Biol Chem. 1999;274(40):28528–36.CrossRefPubMed
22.
Dreveny I, Deeves SE, Fulton J, Yue B, Messmer M, Bhattacharya A, et al. The double PHD finger domain of MOZ/MYST3 induces alpha-helical structure of the histone H3 tail to facilitate acetylation and methylation sampling and modification. Nucleic Acids Res. 2014;42(2):822–35.CrossRefPubMed
23.
Yang XJ. MOZ and MORF acetyltransferases: molecular interaction, animal development and human disease. Biochim Biophys Acta. 2015;1853(8):1818–26.CrossRefPubMed
24.
Wiesel-Motiuk N, Assaraf YG. The key roles of the lysine acetyltransferases KAT6A and KAT6B in physiology and pathology. Drug Resist updates: reviews commentaries Antimicrob anticancer Chemother. 2020;53:100729.CrossRef
25.
Baell JB, Leaver DJ, Hermans SJ, Kelly GL, Brennan MS, Downer NL, et al. Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth. Nature. 2018;560(7717):253–7.CrossRefPubMed
26.
Liang Y, Su Y, Xu C. Protein kinase D1 phosphorylation of KAT7 enhances its protein stability and promotes replication licensing and cell proliferation. Cell Death Discov. 2020;6:89.CrossRefPubMedPubMedCentral
27.
Wang W, Zheng Y. A genome-wide CRISPR-based screen identifies KAT7 as a driver of cellular senescence. Sci Transl Med. 2021;13(575):eabd2655.CrossRefPubMed
28.
Wang Y, Chen S, Tian W, Zhang Q, Jiang C, Qian L, et al. High-expression HBO1 predicts poor prognosis in gastric Cancer. Am J Clin Pathol. 2019;152(4):517–26.CrossRefPubMed
29.
Singh M, Bacolla A, Chaudhary S, Hunt CR, Pandita S, Chauhan R, et al. Histone acetyltransferase MOF orchestrates outcomes at the crossroad of Oncogenesis, DNA damage response, proliferation, and Stem Cell Development. Mol Cell Biol. 2020;40(18):e00232–20.CrossRefPubMedPubMedCentral
30.
Pessoa Rodrigues C, Chatterjee A, Wiese M. Histone H4 lysine 16 acetylation controls central carbon metabolism and diet-induced obesity in mice. 2021;12(1):6212.
31.
Sheikh BN, Bechtel-Walz W, Lucci J, Karpiuk O, Hild I, Hartleben B, et al. MOF maintains transcriptional programs regulating cellular stress response. Oncogene. 2016;35(21):2698–710.CrossRefPubMed
32.
Xu Y, Wan W. Acetylation in the regulation of autophagy. Autophagy. 2022:1–9.
33.
Li Q, Sun H, Shu Y, Zou X, Zhao Y, Ge C. hMOF (human males absent on the first), an oncogenic protein of human oral tongue squamous cell carcinoma, targeting EZH2 (enhancer of zeste homolog 2). Cell Prolif. 2015;48(4):436–42.CrossRefPubMedPubMedCentral
34.
Qi Y, Tan M, Zheng M, Jin S, Wang H, Liu J, et al. Estrogen/estrogen receptor promotes the proliferation of endometrial carcinoma cells by enhancing hMOF expression. Jpn J Clin Oncol. 2020;50(3):241–53.CrossRefPubMedPubMedCentral
35.
Dong Z, Zou J, Li J, Pang Y, Liu Y, Deng C, et al. MYST1/KAT8 contributes to tumor progression by activating EGFR signaling in glioblastoma cells. Cancer Med. 2019;8(18):7793–808.CrossRefPubMedPubMedCentral
36.
Wu Y, Zeng K, Wang C, Wang S, Sun H, Liu W, et al. Histone acetyltransferase MOF is involved in suppression of endometrial cancer and maintenance of ERα stability. Biochem Biophys Res Commun. 2019;509(2):541–8.CrossRefPubMed
37.
38.
Meizhen C, Kaoru T, Olivia MP. The emerging role of the MORF/MRG Gene Family in various biological processes including aging. Ann N Y Acad Sci 1197:134–41.
Metadata
Title
Expression profiles and functional prediction of histone acetyltransferases of the MYST family in kidney renal clear cell carcinoma
Authors
Fan Liang
Xiangke Li
Xiaoman Shen
Runlei Yang
Chuan Chen
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2023
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-023-11076-x

Other articles of this Issue 1/2023

BMC Cancer 1/2023 Go to the issue

Research

PCDH1, a poor prognostic biomarker and potential target for pancreatic adenocarcinoma metastatic therapy

Research

Survival differences between patients with de novo and relapsed/progressed advanced non-small cell lung cancer without epidermal growth factor receptor mutations or anaplastic lymphoma kinase rearrangements

Research

Levels of type XVII collagen (BP180) ectodomain are elevated in circulation from patients with multiple cancer types and is prognostic for patients with metastatic colorectal cancer

Research

Intratumoral and peritumoral radiomics based on contrast-enhanced MRI for preoperatively predicting treatment response of transarterial chemoembolization in hepatocellular carcinoma

Research

Functional analyses of rare germline BRCA1 variants by transcriptional activation and homologous recombination repair assays

Research

Clinical characteristics and prognostic factors affecting survival after radical radiotherapy for early and late post-treatment metastatic nasopharyngeal carcinoma

2024 ASCO Annual Meeting Coverage

Highlights of the Day: Breast cancer – metastatic

Breast Cancer Video

In this session, Dr. Wolff provides his key takeaways from the data presented in the metastatic breast cancer oral abstract session at ASCO 2024.

Watch now

Highlights of the Day: Gynecologic cancer

Gynecologic Cancer Video

Highlights of the Day: Breast Cancer – local/regional/adjuvant

Breast Cancer Video

Neoadjuvant dual immunotherapy improves melanoma outcomes

04-06-2024 Melanoma News

» View more highlights on the ASCO 2024 congress hub page

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits